Diploma PLC (LON:DPLM)

Revenue by Geography

Financials in millions GBP. Fiscal year is October - September.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016	Sep 30, 2015	Sep 30, 2014	Sep 30, 2013	Sep 30, 2012
United Kingdom Revenue	306.80M	279.80M	273.00M
United Kingdom Revenue Growth	9.65%	2.49%	2.21%
Rest of Europe Revenue	270.60M	247.50M	267.80M
Rest of Europe Revenue Growth	9.33%	-7.58%	27.34%
USA Revenue	869.20M	802.60M	626.10M
USA Revenue Growth	8.30%	28.19%	16.46%
Rest of World Revenue	200.50M	194.60M	196.50M
Rest of World Revenue Growth	3.03%	-0.97%	6.04%
Revenue (Total)	1.65B	1.52B	1.36B
Revenue (Total) Growth	8.04%	11.82%	13.59%

Revenue

Financials in millions GBP. Fiscal year is October - September.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016	Sep 30, 2015	Sep 30, 2014	Sep 30, 2013	Sep 30, 2012
Controls Revenue	940.40M	836.40M	652.40M
Controls Revenue Growth	12.43%	28.20%	14.78%
Seals Revenue	454.20M	456.00M	489.10M
Seals Revenue Growth	-0.40%	-6.77%	16.73%
Life Sciences Revenue	252.50M	232.10M	221.90M
Life Sciences Revenue Growth	8.79%	4.60%	4.23%
Revenue (Total)	1.65B	1.52B	1.36B
Revenue (Total) Growth	8.04%	11.82%	13.59%

Adjusted EBIT by Geography

Financials in millions GBP. Fiscal year is October - September.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016	Sep 30, 2015	Sep 30, 2014	Sep 30, 2013	Sep 30, 2012
United Kingdom Adjusted Operating Profit	8.20M	8.60M	23.30M
United Kingdom Adjusted Operating Profit Growth	-4.65%	-63.09%	-19.10%
Rest of Europe Adjusted Operating Profit	53.60M	48.30M	53.90M
Rest of Europe Adjusted Operating Profit Growth	10.97%	-10.39%	56.23%
USA Adjusted Operating Profit	294.60M	248.50M	165.50M
USA Adjusted Operating Profit Growth	18.55%	50.15%	25.19%
Rest of World Adjusted Operating Profit	38.30M	37.30M	42.30M
Rest of World Adjusted Operating Profit Growth	2.68%	-11.82%	1.93%
Operating Income (Other)	-85.30M	-59.00M	-77.60M
Operating Income (Total)	309.40M	283.70M	207.40M
Operating Income (Total) Growth	9.06%	36.79%	13.15%

Adjusted EBIT

Financials in millions GBP. Fiscal year is October - September.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016	Sep 30, 2015	Sep 30, 2014	Sep 30, 2013	Sep 30, 2012
Controls Adjusted Operating Profit	301.90M	250.60M	169.90M
Controls Adjusted Operating Profit Growth	20.47%	47.50%	24.38%
Seals Adjusted Operating Profit	88.20M	88.10M	90.70M
Seals Adjusted Operating Profit Growth	0.11%	-2.87%	14.81%
Life Sciences Adjusted Operating Profit	49.30M	45.30M	46.80M
Life Sciences Adjusted Operating Profit Growth	8.83%	-3.21%	8.33%
Corporate Adjusted Operating Profit	-44.70M	-41.30M	-22.40M
Operating Income (Other)	-85.30M	-59.00M	-77.60M
Operating Income (Total)	309.40M	283.70M	207.40M
Operating Income (Total) Growth	9.06%	36.79%	13.15%

EBIT

Financials in millions GBP. Fiscal year is October - September.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016	Sep 30, 2015	Sep 30, 2014	Sep 30, 2013	Sep 30, 2012
Controls Operating Profit	256.20M	211.20M	132.30M
Controls Operating Profit Growth	21.31%	59.64%	17.18%
Seals Operating Profit	60.40M	79.00M	62.20M
Seals Operating Profit Growth	-23.54%	27.01%	11.47%
Life Sciences Operating Profit	37.50M	34.80M	35.30M
Life Sciences Operating Profit Growth	7.76%	-1.42%	-3.02%
Corporate Operating Profit	-44.70M	-41.30M	-22.40M
Operating Income (Total)	309.40M	283.70M	207.40M
Operating Income (Total) Growth	9.06%	36.79%	13.15%

Key Performance Indicators

Financials in millions GBP. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016	Sep 30, 2015	Sep 30, 2014	Sep 30, 2013	Sep 30, 2012
Life Sciences Organic Growth	6.00%	6.00%
Seals Organic Growth	2.00%	1.00%
Controls Organic Growth	20.00%	10.00%
Group Organic Growth	11.00%	6.00%

Data Source: Fiscal.ai Last updated: May 19, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 5, 2026

Data Sources Report a data error